D.E. Shaw & Co
SRTS icon

D.E. Shaw & Co’s Sensus Healthcare SRTS Stock Holding History

D.E. Shaw & Co’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,535
Closed -$40K – 4825
2024
Q1 		$40K Sell
10,535
-52,221
-83% -$189K ﹤0.01% 4081
2023
Q4 		$148K Sell
62,756
-13,038
-17% -$30.5K ﹤0.01% 3927
2023
Q3 		$210K Sell
75,794
-16,982
-18% -$51.9K ﹤0.01% 3743
2023
Q2 		$292K Sell
92,776
-19
-0% -$69 ﹤0.01% 3603
2023
Q1 		$483K Buy
92,795
+11,823
+15% +$84.9K ﹤0.01% 3571
2022
Q4 		$601K Buy
80,972
+55,822
+222% +$504K ﹤0.01% 3756
2022
Q3 		$315K Buy
25,150
+5,555
+28% +$66.4K ﹤0.01% 4275
2022
Q2 		$150K Buy
+19,595
New +$164K ﹤0.01% 4641

Other funds holding SRTS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

D.E. Shaw & Co's SRTS Position: Q2 2024 in Review

D.E. Shaw & Co sold out of Sensus Healthcare (SRTS) in Q2 2024, closing a stake of 10,535 shares — an estimated $40K sold.

D.E. Shaw & Co first reported a position in SRTS in Q2 2022 and held it in 8 quarters. The position peaked at $601K in Q4 2022. 47 funds tracked by Wall St. Rank hold SRTS as of Q2 2024.

  • D.E. Shaw & Co reported no remaining Sensus Healthcare position as of Q2 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 10,535 Sensus Healthcare shares in Q2 2024, an estimated $40K.
  • D.E. Shaw & Co first reported a position in Sensus Healthcare in Q2 2022 and held it in 8 quarters.
  • D.E. Shaw & Co's Sensus Healthcare position peaked at $601K in Q4 2022.
  • 47 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2024.

Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.